Adrenergic Neural Cells are a subset of neurons that release the neurotransmitter norepinephrine, also known as noradrenaline. These cells are part of the sympathetic nervous system, a branch of the autonomic nervous system responsible for the "fight or flight" response. Adrenergic neurons play a crucial role in regulating various physiological functions, including heart rate, blood pressure, and the mobilization of energy resources. The release of norepinephrine from adrenergic neural cells activates adrenergic receptors on target tissues, leading to physiological responses such as increased heart rate, bronchodilation, and heightened alertness. Adrenergic signaling is essential for the body's response to stress and emergencies. Dysregulation of adrenergic neural cells is implicated in several medical conditions, including hypertension, heart failure, and certain neurological disorders. Medications that target adrenergic receptors are commonly used to manage conditions like hypertension and cardiac arrhythmias. Researchers study adrenergic neural cells to gain insights into the mechanisms of sympathetic nervous system function and to develop therapeutic interventions for conditions related to autonomic dysfunction. Understanding adrenergic signaling pathways provides avenues for developing drugs that selectively modulate sympathetic activity for improved treatment outcomes.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy